Artículos del autor

solaci

Institutional News

SOLACI CACI ‘21 VIRTUAL CONGRESS – Save the New Date

Official Statement Given the complex epidemiological emergency worldwide (especially in Argentina) caused by COVID-19, the authorities of SOLACI-CACI 2021...
solaci -
Institutional News

06/10 | SOLACI Webinar – Pressure Gradients After TAVR: Paradigm Shift?

solaci -
Scientific Articles COVID-19

Myocarditis and Messenger RNA COVID-19 Vaccine: What Is the Risk?

European and American agencies (such as the Centers for Disease Control ) have begun evaluating reports on...
solaci -
Scientific Articles COVID-19

Pfizer/BioNTech Vaccine against COVID-19 in Teenagers

COVID-19 vaccine developed by Pfizer/BioNTech had an excellent safety profile and remarkably high efficacy (100%) in teenagers. The...
solaci -
Institutional News

Webinar SOLACI | TAVI Optimizing Implanting Techniques in Challenging Scenarios

solaci -
CORONARY DISEASE

EuroPCR 2021 | CASTLE: Orsiro vs Xience Guided by Intravascular Imaging

According to the CASTLE trial, the Orsino stent—a biodegradable, ultrathin, sirolimus-eluting stent—provides the same results at 12 months...
solaci -
Chronic Ischemic cardiopathy

EuroPCR 2021 | EBC MAIN: Provisional Stenting vs. Systematic Dual Stenting in Left Main Coronary Artery

Treating the left main coronary artery with provisional stenting was non-inferior to systematic dual stenting in the...
solaci -
STRUCTURAL HEART DISEASE

EuroPCR 2021 | Evolut Low Risk: Two-Year Results of The Self-Expanding Valve in Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) with the Evolut self-expanding valve was non-inferior to surgery in patients with...
solaci -